Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Royal Brompton Hospital

Global Molecular Diagnostics Market To Reach $7.3B By 2019

The global molecular diagnostics market will grow by $2.4 billion over the next five years according to a global market report from Medtech Insight. Major factors contributing to the healthy growth of this market include advances in technology, as well as the growing understanding of the human genome, pharmacogenomics and the relationship between genes and disease/infection.

Medical Device Innovation

Emphysema Devices Search for Breathing Room

Interventional pulmonology is a burgeoning field for medical device manufacturers. It is ripe with opportunities to develop minimally invasive solutions for patients with chronic progressive lung disease. Emphysema, which afflicts close to 2% of the world's population, is a prime target. With an opportunity as large as this driving innovation and investment, the right combination of technology and clinical trial design could spell blockbuster success for medtech companies.

Medical Device

ESC Highlights: DES Debate Continues, Hybrid-Imaging Hot Ticket

Heart failure was the theme at this year's European Society of Cardiology Congress in Vienna, but drug-eluting stents dominated interest with imaging sessions also drawing crowds.

Medical Device
See All

Company Information

  • Industry
  • Services
    • Hospitals, Nursing Homes, Institutions